Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D 3 during osteoblast-lineage cell differentiation

Journal of Biological Chemistry

Volumn 289, Issue 28, 2014, Pages 19539-19554

  Meyer, Mark B ^a   Benkusky, Nancy A ^a   Lee, Chang Hun ^a   Pike, J Wesley ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; GENE EXPRESSION;

BIOLOGICAL EFFECTS; CCAAT/ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CHIP SEQUENCES; GENE INTERACTIONS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTOMES; VITAMIN D RECEPTOR;

OSTEOBLASTS;

CALCITRIOL; CCAAT ENHANCER BINDING PROTEIN BETA; CISTROME; NUCLEIC ACID; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTOME; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEPLETION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC REGULATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

CCAAT/ENHANCER-BINDING PROTEIN (C/EBP); CHIP-SEQUENCING (CHIP-SEQ); CHROMATIN MODIFICATION; OSTEOBLAST; TRANSCRIPTION ENHANCER; VITAMIN D;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; GENETIC LOCI; MICE; OSTEOBLASTS; RECEPTORS, CALCITRIOL; TRANSCRIPTION FACTORS;

EID: 84904190176     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.578104     Document Type: Article

References (68)

1. Lieben, L., Carmeliet, G., and Masuyama, R. (2011) Calcemic actions of vitamin D: effects on the intestine, kidney and bone. Best Pract. Res. Clin. Endocrinol. Metab. 25, 561-572
2. Bikle, D. D. (2012) Vitamin D and bone. Curr. Osteoporos Rep. 10, 151-159
3. Eisman, J. A., and Bouillon, R. (2014) Vitamin D: direct effects of vitamin D metabolites on bone: lessons from genetically modified mice. Bonekey Rep. 3, 499
4. Plum, L. A., and DeLuca, H. F. (2010) Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 9, 941-955
5. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176 (Pubitemid 28180851)
6. Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., and Yamashita, T. (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. U.S.A. 98, 6500-6505 (Pubitemid 32488266)
7. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., and Yamashita, T. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568 (Pubitemid 38542505)
8. Inoue, Y., Segawa, H., Kaneko, I., Yamanaka, S., Kusano, K., Kawakami, E., Furutani, J., Ito, M., Kuwahata, M., Saito, H., Fukushima, N., Kato, S., Kanayama, H. O., and Miyamoto, K. (2005) Role of the vitamin D receptor in FGF23 action on phosphate metabolism. Biochem. J. 390, 325-331 (Pubitemid 41192259)
9. Bouillon, R., Bischoff-Ferrari, H., and Willett, W. (2008) Vitamin D and health: perspectives from mice and man. J. Bone Miner. Res. 23, 974-979 (Pubitemid 351915717)
10. Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., and Demay, M. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29, 726-776
11. Lieben, L., and Carmeliet, G. (2013) The delicate balance between vitamin D, calcium and bone homeostasis: lessons learned from intestinal- and osteocyte-specific VDR null mice. J. Steroid Biochem. Mol. Biol. 136, 102-106
12. Dardenne, O., Prud'homme, J., Arabian, A., Glorieux, F. H., and St-Arnaud, R. (2001) Targeted inactivation of the 25-hydroxyvitamin D(3)-1(α)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142, 3135-3141 (Pubitemid 32575552)
13. Amling, M., Priemel, M., Holzmann, T., Chapin, K., Rueger, J. M., Baron, R., and Demay, M. B. (1999) Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140, 4982-4987
14. Panda, D. K., Miao, D., Bolivar, I., Li, J., Huo, R., Hendy, G. N., and Goltzman, D. (2004) Inactivation of the 25-hydroxyvitamin D 1α-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J. Biol. Chem. 279, 16754-16766 (Pubitemid 38509378)
15. Gardiner, E. M., Baldock, P. A., Thomas, G. P., Sims, N. A., Henderson, N. K., Hollis, B., White, C. P., Sunn, K. L., Morrison, N. A., Walsh, W. R., and Eisman, J. A. (2000) Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J. 14, 1908-1916
16. Lieben, L., Masuyama, R., Torrekens, S., Van Looveren, R., Schrooten, J., Baatsen, P., Lafage-Proust, M. H., Dresselaers, T., Feng, J. Q., Bonewald, L. F., Meyer, M. B., Pike, J. W., Bouillon, R., and Carmeliet, G. (2012) Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J. Clin. Invest. 122, 1803-1815
17. Pike, J. W., and Meyer, M. B. (2013) Fundamentals of vitamin D hormone-regulated gene expression. J. Steroid Biochem. Mol. Biol. 10.1016/j.jsbmb.2013.11.004
18. Pike, J. W., Lee, S. M., and Meyer, M. B. (2014) Regulation of gene expression by 1,25-dihydroxyvitamin D3 in bone cells: exploiting new approaches and defining new mechanisms. Bonekey Rep. 3, 482
19. Meyer, M. B., Goetsch, P. D., and Pike, J. W. (2010) A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1α,25-dihydroxyvitamin D3. J. Biol. Chem. 285, 15599-15610
20. Meyer, M. B., Goetsch, P. D., and Pike, J. W. (2010) Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J. Steroid Biochem. Mol. Biol. 121, 136-141
21. de Wit, E., and de Laat, W. (2012) A decade of 3C technologies: insights into nuclear organization. Genes Dev. 26, 11-24
22. Dowd, D. R., Sutton, A. L., Zhang, C., and MacDonald, P. N. (2005) in Vitamin D (Feldman, D., Pike, J. W., and Glorieux, F. H., eds) 2nd Ed., pp. 291-304, Elsevier/Academic Press, New York
23. Meyer, M. B., and Pike, J. W. (2013) Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1α,25- dihydroxyvitamin D3-responsive genes. J. Steroid Biochem. Mol. Biol. 136, 120-124
24. Murayama, A., Kim, M. S., Yanagisawa, J., Takeyama, K., and Kato, S. (2004) Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 23, 1598-1608 (Pubitemid 38579520)
25. Sudo, H., Kodama, H. A., Amagai, Y., Yamamoto, S., and Kasai, S. (1983) In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96, 191-198 (Pubitemid 13155577)
26. Elford, P. R., Felix, R., Cecchini, M., Trechsel, U., and Fleisch, H. (1987) Murine osteoblastlike cells and the osteogenic cell MC3T3-E1 release a macrophage colony-stimulating activity in culture. Calcif. Tissue Int. 41, 151-156
27. Udagawa, N., Takahashi, N., Akatsu, T., Sasaki, T., Yamaguchi, A., Kodama, H., Martin, T. J., and Suda, T. (1989) The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125, 1805-1813 (Pubitemid 19258613)
28. Meyer, M. B., Benkusky, N. A., and Pike, J. W. (2014) The RUNX2 cistrome in osteoblasts: characterization, down-regulation following differentiation and relationship to gene expression. J. Biol. Chem. 289, 16016-16031
29. Meyer, M. B., Watanuki, M., Kim, S., Shevde, N. K., and Pike, J. W. (2006) The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol. 20, 1447-1461 (Pubitemid 43801243)
30. Kim, S., Yamazaki, M., Zella, L. A., Shevde, N. K., and Pike, J. W. (2006) Activation of receptor activator of NF-κB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol. Cell. Biol. 26, 6469-6486 (Pubitemid 44277887)
31. Yamamoto, H., Shevde, N. K., Warrier, A., Plum, L. A., DeLuca, H. F., and Pike, J. W. (2003) 2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblasts. J. Biol. Chem. 278, 31756-31765 (Pubitemid 37048356)
32. Meyer, M. B., Goetsch, P. D., and Pike, J. W. (2012) VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol. Endocrinol. 26, 37-51
33. Kriebitzsch, C., Verlinden, L., Eelen, G., van Schoor, N. M., Swart, K., Lips, P., Meyer, M. B., Pike, J. W., Boonen, S., Carlberg, C., Vitvitsky, V., Bouillon, R., Banerjee, R., and Verstuyf, A. (2011) 1,25-Dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase. J. Bone Miner. Res. 26, 2991-3000
34. Carlberg, C., Dunlop, T. W., Saramäki, A., Sinkkonen, L., Matilainen, M., and Väisänen, S. (2007) Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites. J. Steroid Biochem. Mol. Biol. 103, 338-343 (Pubitemid 46401335)
35. Meyer, M. B., Benkusky, N. A., and Pike, J. W. (2013) 1,25-Dihydroxyvitamin D3 induced histone profiles guide discovery of VDR action sites. J. Steroid Biochem. Mol. Biol. 10.1016/j.jsbmb.2013.09.005
36. Meyer, M. B., Zella, L. A., Nerenz, R. D., and Pike, J. W. (2007) Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo. J. Biol. Chem. 282, 22344-22352 (Pubitemid 47267363)
37. Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G. F., Wang, Q., Bekiranov, S., Sementchenko, V., Fox, E. A., Silver, P. A., Gingeras, T. R., Liu, X. S., and Brown, M. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38, 1289-1297 (Pubitemid 44646291)
38. Nielsen, R., Pedersen, T. A., Hagenbeek, D., Moulos, P., Siersbaek, R., Megens, E., Denissov, S., Børgesen, M., Francoijs, K. J., Mandrup, S., and Stunnenberg, H. G. (2008) Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 22, 2953-2967
39. Welboren, W. J., Stunnenberg, H. G., Sweep, F. C., and Span, P. N. (2007) Identifying estrogen receptor target genes. Mol. Oncol. 1, 138-143 (Pubitemid 47199132)
40. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M., and Werner, T. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942 (Pubitemid 40916416)
41. McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., and Bejerano, G. (2010) GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501
42. Lian, J. B., Stein, J. L., Stein, G. S., Montecino, M., van Wijnen, A. J., Javed, A., and Gutierrez, S. (2001) Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene. Steroids 66, 159-170 (Pubitemid 32140895)
43. Gutierrez, S., Javed, A., Tennant, D. K., van Rees, M., Montecino, M., Stein, G. S., Stein, J. L., and Lian, J. B. (2002) CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277, 1316-1323 (Pubitemid 34968885)
44. Marcellini, S., Bruna, C., Henríquez, J. P., Albistur, M., Reyes, A. E., Barriga, E. H., Henríquez, B., and Montecino, M. (2010) Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis. BMC Evol. Biol. 10.1186/1471-2148-10-78
45. Ji, X., Li, W., Song, J., Wei, L., and Liu, X. (2006) CEAS: cis-regulatory element annotation system. Nucleic Acids Res. 34, W551-W554 (Pubitemid 44529830)
46. Peng, Y., Shi, K., Wang, L., Lu, J., Li, H., Pan, S., and Ma, C. (2013) Characterization of Osterix protein stability and physiological role in osteoblast differentiation. PLoS One 8, e56451
47. Drissi, H., Pouliot, A., Koolloos, C., Stein, J. L., Lian, J. B., Stein, G. S., and van Wijnen, A. J. (2002) 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp. Cell Res. 274, 323-333
48. Long, F. (2012) Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 13, 27-38
49. Li, G., Ruan, X., Auerbach, R. K., Sandhu, K. S., Zheng, M., Wang, P., Poh, H. M., Goh, Y., Lim, J., Zhang, J., Sim, H. S., Peh, S. Q., Mulawadi, F. H., Ong, C. T., Orlov, Y. L., Hong, S., Zhang, Z., Landt, S., Raha, D., Euskirchen, G., Wei, C. L., Ge, W., Wang, H., Davis, C., Fisher-Aylor, K. I., Mortazavi, A., Gerstein, M., Gingeras, T., Wold, B., Sun, Y., Fullwood, M. J., Cheung, E., Liu, E., Sung, W. K., Snyder, M., and Ruan, Y. (2012) Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148, 84-98
50. Handoko, L., Xu, H., Li, G., Ngan, C. Y., Chew, E., Schnapp, M., Lee, C. W., Ye, C., Ping, J. L., Mulawadi, F., Wong, E., Sheng, J., Zhang, Y., Poh, T., Chan, C. S., Kunarso, G., Shahab, A., Bourque, G., Cacheux-Rataboul, V., Sung, W. K., Ruan, Y., and Wei, C. L. (2011) CTCF-mediated functional chromatin interactome in pluripotent cells. Nat. Genet. 43, 630-638
51. Pike, J. W., Meyer, M. B., Watanuki, M., Kim, S., Zella, L. A., Fretz, J. A., Yamazaki, M., and Shevde, N. K. (2007) Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J. Steroid Biochem. Mol. Biol. 103, 389-395 (Pubitemid 46401339)
52. Zella, L. A., Kim, S., Shevde, N. K., and Pike, J. W. (2006) Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 20, 1231-1247 (Pubitemid 43801228)
53. Zella, L. A., Meyer, M. B., Nerenz, R. D., Lee, S. M., Martowicz, M. L., and Pike, J. W. (2010) Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 24, 128-147
54. Lee, S. M., Bishop, K. A., Goellner, J. J., O'Brien, C. A., and Pike, J. W. (2014) Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype. Endocrinology 155, 10.1210/en.2014-1107
55. Wang, Y., Zhu, J., and DeLuca, H. F. (2014) Identification of the vitamin D receptor in osteoblasts and chondrocytes but not osteoclasts in mouse bone. J. Bone Miner. Res. 29, 685-692
56. Sierra, J., Villagra, A., Paredes, R., Cruzat, F., Gutierrez, S., Javed, A., Arriagada, G., Olate, J., Imschenetzky, M., Van Wijnen, A. J., Lian, J. B., Stein, G. S., Stein, J. L., and Montecino, M. (2003) Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol. Cell. Biol. 23, 3339-3351 (Pubitemid 36459245)
57. Lian, J. B., Javed, A., Zaidi, S. K., Lengner, C., Montecino, M., van Wijnen, A. J., Stein, J. L., and Stein, G. S. (2004) Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit. Rev. Eukaryot. Gene Expr. 14, 1-41 (Pubitemid 38581526)
58. Jensen, E. D., Nair, A. K., and Westendorf, J. J. (2007) Histone deacetylase co-repressor complex control of Runx2 and bone formation. Crit. Rev. Eukaryot. Gene Expr. 17, 187-196 (Pubitemid 46884134)
59. Jensen, E. D., Schroeder, T. M., Bailey, J., Gopalakrishnan, R., and Westendorf, J. J. (2008) Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation- independent manner. J. Bone Miner. Res. 23, 361-372 (Pubitemid 351304666)
60. Schroeder, T. M., Kahler, R. A., Li, X., and Westendorf, J. J. (2004) Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J. Biol. Chem. 279, 41998-42007 (Pubitemid 39313651)
61. Schroeder, T. M., Jensen, E. D., and Westendorf, J. J. (2005) Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res. C Embryo Today 75, 213-225 (Pubitemid 41456323)
62. Jonason, J. H., Xiao, G., Zhang, M., Xing, L., and Chen, D. (2009) Post-translational regulation of Runx2 in bone and cartilage. J. Dent. Res. 88, 693-703
63. Franceschi, R. T., Xiao, G., Jiang, D., Gopalakrishnan, R., Yang, S., and Reith, E. (2003) Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect. Tissue Res. 44, 109-116 (Pubitemid 36395431)
64. Franceschi, R. T., and Xiao, G. (2003) Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J. Cell. Biochem. 88, 446-454 (Pubitemid 36158266)
65. Steinberg, X. P., Hepp, M. I., Fernández García, Y., Suganuma, T., Swanson, S. K., Washburn, M., Workman, J. L., and Gutiérrez, J. L. (2012) Human CCAAT/enhancer-binding protein β interacts with chromatin remodeling complexes of the imitation switch subfamily. Biochemistry 51, 952-962
66. Dallas, S. L., and Bonewald, L. F. (2010) Dynamics of the transition from osteoblast to osteocyte. Ann. N.Y. Acad. Sci. 1192, 437-443
67. Liu, J. C., Lengner, C. J., Gaur, T., Lou, Y., Hussain, S., Jones, M. D., Borodic, B., Colby, J. L., Steinman, H. A., van Wijnen, A. J., Stein, J. L., Jones, S. N., Stein, G. S., and Lian, J. B. (2011) Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation. J. Biol. Chem. 286, 30057-30070
68. Nishio, Y., Dong, Y., Paris, M., O'Keefe, R. J., Schwarz, E. M., and Drissi, H. (2006) Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372, 62-70